Filing Details
- Accession Number:
- 0001209191-14-070367
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-20 16:49:08
- Reporting Period:
- 2014-11-18
- Filing Date:
- 2014-11-20
- Accepted Time:
- 2014-11-20 16:49:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1289408 | Keith Valentine | 7475 Lusk Blvd. San Diego CA 92121 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-11-18 | 20,000 | $18.31 | 92,736 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-11-18 | 14,418 | $43.97 | 78,318 | No | 4 | F | Direct | |
Common Stock | Disposition | 2014-11-19 | 5,582 | $43.32 | 72,736 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-11-18 | 20,000 | $0.00 | 20,000 | $18.31 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-01-03 | No | 4 | M | Direct |
Footnotes
- Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
- Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on December 12, 2013, which is intended to comply with Rule 10b5-1.
- Weighted average from 38 transactions with prices ranging from $42.9900 to $43.7800. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
- The option, representing a right to purchase a total of 81,534 shares, became exercisable as follows: 25% of the shares vested on January 3, 2007; 1/48th of the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2010, subject to continued employment through each vesting period.